Literature DB >> 21604673

Convergent and stereodivergent synthesis of complex 1-aza-7-oxabicyclo[2.2.1]heptanes.

Dexi Yang1, Glenn C Micalizio.   

Abstract

A convergent and stereodivergent pathway to highly substituted 1-aza-7-oxabicyclo[2.2.1]heptanes is described. It begins with a coupling reaction involving allylic alcohol, aldehyde, and LiHMDS to produce stereodefined primary homoallylic amines. Subsequent N-oxidation and condensation with formaldehyde or glyoxylate defines a convenient entry to densely functionalized homoallylic nitrones whose intramolecular annulation can be controlled to deliver one of two distinct heterocyclic skeletons, each with ≥20:1 stereoselection. Control of the stereochemistry in these reactions results from both control of the nitrone geometry and selective partitioning of the reaction pathway between direct [3 + 2] cycloaddition and tandem [3,3] rearrangement/[3 + 2] cycloaddition.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21604673      PMCID: PMC3116711          DOI: 10.1021/ja202900h

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  5 in total

1.  Preparation of stereodefined homoallylic amines from the reductive cross-coupling of allylic alcohols with imines.

Authors:  Ming Z Chen; Martin McLaughlin; Masayuki Takahashi; Michael A Tarselli; Dexi Yang; Shuhei Umemura; Glenn C Micalizio
Journal:  J Org Chem       Date:  2010-11-11       Impact factor: 4.354

2.  Copper-catalyzed electrophilic amination of organozinc nucleophiles: documentation of O-benzoyl hydroxylamines as broadly useful R2N(+) and RHN(+) synthons.

Authors:  Ashley M Berman; Jeffrey S Johnson
Journal:  J Org Chem       Date:  2006-01-06       Impact factor: 4.354

3.  A convergent stereoselective synthesis of quinolizidines and indolizidines: chemoselective coupling of 2-hydroxymethyl-substituted allylic silanes with imines.

Authors:  Dexi Yang; Glenn C Micalizio
Journal:  J Am Chem Soc       Date:  2009-12-09       Impact factor: 15.419

4.  Convergent synthesis of stereodefined exo-alkylidene-gamma-lactams from beta-halo allylic alcohols.

Authors:  Shuhei Umemura; Martin McLaughlin; Glenn C Micalizio
Journal:  Org Lett       Date:  2009-12-03       Impact factor: 6.005

5.  Complex allylation by the direct cross-coupling of imines with unactivated allylic alcohols.

Authors:  Masayuki Takahashi; Martin McLaughlin; Glenn C Micalizio
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

  5 in total
  6 in total

1.  Reaction design, discovery, and development as a foundation to function-oriented synthesis.

Authors:  Glenn C Micalizio; Sarah B Hale
Journal:  Acc Chem Res       Date:  2015-02-10       Impact factor: 22.384

2.  Three-component coupling sequence for the regiospecific synthesis of substituted pyridines.

Authors:  Ming Z Chen; Glenn C Micalizio
Journal:  J Am Chem Soc       Date:  2011-12-14       Impact factor: 15.419

3.  Catalytic Z-selective cross-metathesis with secondary silyl- and benzyl-protected allylic ethers: mechanistic aspects and applications to natural product synthesis.

Authors:  Tyler J Mann; Alexander W H Speed; Richard R Schrock; Amir H Hoveyda
Journal:  Angew Chem Int Ed Engl       Date:  2013-06-21       Impact factor: 15.336

4.  Stereochemical lability of azatitanacyclopropanes: dynamic kinetic resolution in reductive cross-coupling reactions with allylic alcohols.

Authors:  Dexi Yang; Glenn C Micalizio
Journal:  Chem Commun (Camb)       Date:  2013-10-09       Impact factor: 6.222

5.  Synthesis of alkaloid (-)-205B via stereoselective reductive cross-coupling and intramolecular [3+2] cycloaddition.

Authors:  Dexi Yang; Glenn C Micalizio
Journal:  J Am Chem Soc       Date:  2012-09-07       Impact factor: 15.419

6.  Synthesis of Highly Oxygenated Carbocycles by Stereoselective Coupling of Alkynes to 1,3- and 1,4-Dicarbonyl Systems.

Authors:  Matthew J Kier; Robert M Leon; Natasha F O'Rourke; Arnold L Rheingold; Glenn C Micalizio
Journal:  J Am Chem Soc       Date:  2017-09-01       Impact factor: 15.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.